- Home
- HWM vs TAK Comparison
HWM vs TAK Comparison
Compare HWM & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWM
- TAK
- Stock Information
- Founded
- HWM 1888
- TAK 1781
- Country
- HWM United States
- TAK Japan
- Employees
- HWM N/A
- TAK N/A
- Industry
- HWM Metal Fabrications
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- HWM Industrials
- TAK Health Care
- Exchange
- HWM Nasdaq
- TAK Nasdaq
- Market Cap
- HWM 50.9B
- TAK 41.1B
- IPO Year
- HWM N/A
- TAK N/A
- Fundamental
- Price
- HWM $127.15
- TAK $13.11
- Analyst Decision
- HWM Buy
- TAK
- Analyst Count
- HWM 16
- TAK 0
- Target Price
- HWM $115.67
- TAK N/A
- AVG Volume (30 Days)
- HWM 2.3M
- TAK 1.7M
- Earning Date
- HWM 02-13-2025
- TAK 01-30-2025
- Dividend Yield
- HWM 0.25%
- TAK 4.84%
- EPS Growth
- HWM 69.15
- TAK 49.73
- EPS
- HWM 2.60
- TAK 1.27
- Revenue
- HWM $7,270,000,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- HWM $12.85
- TAK $6.15
- Revenue Next Year
- HWM $8.37
- TAK $0.86
- P/E Ratio
- HWM $48.16
- TAK $20.35
- Revenue Growth
- HWM 13.20
- TAK 9.43
- 52 Week Low
- HWM $55.00
- TAK $12.58
- 52 Week High
- HWM $129.10
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- HWM 73.44
- TAK 45.20
- Support Level
- HWM $110.79
- TAK $12.92
- Resistance Level
- HWM $124.15
- TAK $13.20
- Average True Range (ATR)
- HWM 3.02
- TAK 0.13
- MACD
- HWM 1.66
- TAK 0.00
- Stochastic Oscillator
- HWM 90.69
- TAK 41.53
About HWM Howmet Aerospace Inc.
Howmet Aerospace Inc produces products that are majorly used in aerospace, commercial transportation, and industrial and other markets. The company seeks to provide its customers with solutions through offering differentiated products such as airfoils with cooling and coatings for extreme temperature applications, specially designed fasteners for lightweight composite airframe construction, reduced assembly costs, and lightning strike protection and lightweight aluminum commercial wheels. It has four reportable segments namely, Engine Products, Fastening Systems, Engineered Structures and Forged Wheels.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.